Federal Data Hub › HRSA 340B · JSON
Mazzoni Annex · 340B ID RW424852
Not participatingRW4
Mazzoni Center is a RW4 enrolled in the federal 340B Drug Pricing Program in Philadelphia, PA. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 17 contract-pharmacy arrangement(s) (0 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| WALGREEN EASTERN CO INC | PHILADELPHIA, PA | 2016-10-01 | 2018-04-01 | 4691 |
| WALGREEN EASTERN CO. INC. | PHILADELPHIA, PA | 2016-10-01 | 2018-04-01 | 88408 |
| WALGREEN EASTERN CO., INC. | GLENOLDEN, PA | 2016-10-01 | 2018-04-01 | 6772 |
| WALGREEN EASTERN CO., INC. | KING OF PRUSSIA, PA | 2016-10-01 | 2018-04-01 | 26161 |
| WALGREEN EASTERN CO., INC. | PHILADELPHIA, PA | 2016-10-01 | 2018-04-01 | 5197 |
| WALGREEN EASTERN CO., INC. | PHILADELPHIA, PA | 2016-10-01 | 2018-04-01 | 1420 |
| WALGREEN EASTERN CO., INC. | PHILADELPHIA, PA | 2016-10-01 | 2018-04-01 | 1419 |
| WALGREEN EASTERN CO., INC. | PHILADELPHIA, PA | 2016-10-01 | 2018-04-01 | 6771 |
| WALGREEN EASTERN CO., INC. | PHILADELPHIA, PA | 2016-10-01 | 2018-04-01 | 5945 |
| WALGREEN EASTERN CO., INC. | PHILADELPHIA, PA | 2016-10-01 | 2018-04-01 | 25807 |
| WALGREEN EASTERN CO., INC. | PHILADELPHIA, PA | 2016-10-01 | 2018-04-01 | 4701 |
| WALGREEN EASTERN CO., INC. | PHILADELPHIA, PA | 2016-10-01 | 2018-04-01 | 5943 |
| WALGREEN EASTERN CO., INC. | PHILADELPHIA, PA | 2016-10-01 | 2018-04-01 | 5944 |
| WALGREEN EASTERN CO., INC. | PHILADELPHIA, PA | 2016-10-01 | 2018-04-01 | 4693 |
| WALGREEN EASTERN CO., INC. | PHILADELPHIA, PA | 2016-10-01 | 2018-04-01 | 4695 |
| WALGREEN EASTERN CO., INC. | PHILADELPHIA, PA | 2016-10-01 | 2018-04-01 | 4698 |
| WALGREEN EASTERN CO., INC. | PHILADELPHIA, PA | 2016-10-01 | 2018-04-01 | 5946 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.